NASDAQ
Avalo Therapeutics, Inc. (AVTX) reported revenue of $59.00K and net income of $-78,259,000 for FY 2025, with a net profit margin of -132642.4%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.